RecruitingNot ApplicableNCT06230796

Effects of Functional Electrical Stimulation Assisted Cycling in Patients With Hemiparesis After Stroke

Effects of FES-cycling in Patients With Hemiparesis After Stroke


Sponsor

UGECAM Rhône-Alpes

Enrollment

30 participants

Start Date

Nov 17, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To determine whether active cycling assisted by functional electrical stimulation (FES) Is more effective than active cycling on cardiovascular fitness in post stroke hemiparesis


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Adults with Hemiparesis after an unilateral first ever stroke
  • Able to walk in security
  • Time since stroke within 3 months to 1 year
  • Sufficient cognitive function to understand and perform corresponding tasks

Exclusion Criteria4

  • Any history of neurological disorders or cardiovascular instability
  • High spasticity on ankle, knee, hip muscles
  • Inability to exercise on a cyclo-ergometer
  • Pacemaker and other contraindications of the use of electrical stimulation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFES-cycling

30 minutes of active leg cycling with or without FES applied to the paretic rectus femoris of quadriceps and to the biceps femoris and semitendinosus muscles and gluteus maximus, 3 times/weeks for 8 weeks. During training, participants will be seated on a FES-Cycle (Hepha Bike, Kurage): a cyclo-ergometer (Technogym) combined with a 8 channel controlled stimulator (Motimove-8).

DEVICESHAM-cycling

30 minutes of active leg cycling with SHAM FES applied to the paretic rectus femoris of quadriceps and to the biceps femoris and semitendinosus muscles and gluteus maximus, 3 times/weeks for 8 weeks. During training, participants will be seated on a FES-Cycle (Hepha Bike, Kurage): a cyclo-ergometer (Technogym) combined with a 8 channel controlled stimulator (Motimove-8).


Locations(1)

SMR Val Rosay

Saint-Didier-au-Mont-d'Or, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06230796


Related Trials